Ghana vs IDA total: Antiretroviral therapy coverage for PMTCT
Ghana
99.0%
in 2024
IDA total
84.5%
in 2024
Ghana rank
5th
IDA total rank
8th
Antiretroviral therapy coverage for PMTCT over time
- Ghana
- IDA total
How they compare
Ghana currently reports 99.0% against 84.5% in IDA total, a difference of 14.5%.
That makes Ghana's figure about 1.2 times IDA total's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was IDA total ahead.
Ghana ranks 5th and IDA total ranks 8th of 84 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and IDA total in 2.
Head to head by decade
| Decade | Ghana | IDA total | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.6% | 17.8% | 8.2% | IDA total |
| 2010s | 59.9% | 72.2% | 12.3% | IDA total |
| 2020s | 89.0% | 84.2% | 4.8% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ghana or IDA total?
- Ghana, at 99.0% against 84.5% in IDA total as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ghana and IDA total?
- 14.5%, with Ghana ahead.
- How many years of comparable data are there for Ghana and IDA total?
- 25 years are reported by both, from 2000 to 2024.
- How do Ghana and IDA total rank globally for antiretroviral therapy coverage for pmtct?
- Ghana ranks 5th and IDA total ranks 8th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).